Macrophage, mast cell and T lymphocyte infiltrations are independent predictive biomarkers of primary refractoriness or early relapse in classical Hodgkin lymphoma

Leukemia and Lymphoma

Volumn 54, Issue 1, 2013, Pages 41-45

  Deau, Bénédicte ^a,e   Bachy, Emmanuel ^b   Ribrag, Vincent ^c   Delarue, Richard ^a   Rubio, Marie Thérèse ^d   Bosq, Jacques ^c   Varet, Bruno ^a   Brousse, Nicole ^a   Hermine, Olivier ^a   Canioni, Danielle ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b CENTRE HOSPITALIER LYON SUD   (France)

^c INSTITUT GUSTAVE ROUSSY   (France)

^d HÔPITAL SAINT ANTOINE   (France)

^e Cochin Hospital ^*  (France)

Author keywords

Early relapse; Hodgkin lymphoma; Microenvironment biomarkers; Primary refractory disease; Tumor associated macrophages

Indexed keywords

CD68 ANTIGEN;

ADULT; ARTICLE; CANCER RECURRENCE; CLASSICAL HODGKIN LYMPHOMA; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HUMAN; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REFRACTORY PERIOD; RETROSPECTIVE STUDY; TREATMENT RESPONSE; TUMOR ASSOCIATED LEUKOCYTE;

ADULT; AGED; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; FEMALE; HODGKIN DISEASE; HUMANS; MACROPHAGES; MALE; MAST CELLS; MIDDLE AGED; NEOPLASM STAGING; POLY(A)-BINDING PROTEINS; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-KIT; RECURRENCE; T-LYMPHOCYTES; TUMOR MARKERS, BIOLOGICAL; TUMOR MICROENVIRONMENT;

EID: 84870893593     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2012.698274     Document Type: Article

References (15)

1. J F, A braira V,et al. I nfl uence of biologic markers on the outcome of Hodgkin's lymphoma: A study by the Spanish Hodgkin' s Lymphoma Study Group. J Clin Oncol 2004; 22: 1664- 1673. (Pubitemid 41079805)
2. Diehl V, Stein H, Hummel M, et al. Hodgkin's lymphoma: Biology and treatment strategies for primary, refractory, and relapsed disease. Hematology Am Soc Hematol Educ Program 2003: 225 - 247.
3. Josting A, Rueff er U, Franklin J, et al. Prognostic factors and treatment outcome in primary progressive Hodgkin lymphoma: A report from the German Hodgkin Lymphoma Study Group. Blood 2000; 96: 1280 - 1286. (Pubitemid 30658456)
4. D eVita V T J r, C osta J. T oward a personalized treatment of Hogkin' s disease. N Engl J Med 2010; 362: 942- 943.
5. Hasenclever D, Diehl V. A prognostic score for advanced Hodgkin's disease: International Prognostic Factors Project on Advanced Hodgkin' s disease. N Engl J Med 1998; 339: 1506- 1514.
6. K u p pers R. The biology of Hodgkin' s lymphoma. N at Rev Cancer 2009 ; 9: 15 - 27.
7. C anioni D, D eau-Fischer B, T aupin P,et al. P rognostic signifi cance of new immunohistochemical markers in refractory classical Hodgkin lymphoma: A study of 59 cases. PLoS One 2009; 4: E6341.
8. Molin D, Eds trom A, Glimelius I, et al. Mast cell infi ltration correlates with poor prognosis in Hodgkin's lymphoma. Br J Haematol 2002; 119: 122 - 124. (Pubitemid 35176509)
9. Asano N, Oshiro A, Matsuo K, et al. Prognostic signifi cance of T-cell or cytotoxic molecules phenotype in classical Hodgkin's lymphoma: A clinicopathological study. J Clin Oncol 2006; 24: 4626 - 4633. (Pubitemid 46630961)
10. Steidl C, Lee T, Shah SP, et al. Tumor-associated macrophages and survival in classic Hodgkin' s lymphoma. N Engl J Med 2010; 362: 875 - 885.
11. Kamper P, Bendix F, Hamilton-Dutoit S. Tumor-associated macrophages correlate with adverse prognosis and EBV status in classical Hodgkin lymphoma. Haematologica 2011; 96: 269- 276.
12. Tzankov A, Matter MS, Dirnhofer S. Refi ned prognostic role of CD68-positive tumor macrophages in the context of the cellular micromilieu of classical Hodgkin lymphoma. Pathobiology 2010; 77: 301 - 308.
13. Z aki M A, W ada N, I keda J,et al. P rognostic implication of types of tumor-associated macrophages in Hodgkin lymphoma. Virchows Arch 2011; 459: 361 - 366.
14. Azambuja D, Natkunam Y, Biasoli I, et al. Lack of association of tumor-associated macrophages with clinical outcome in patients with classical Hodgkin' s lymphoma. Ann Oncol 2012; 23: 736- 742.
15. Steidl C, Connors JM, Gascoygne RD. Molecular pathogenesis of Hodgkin's lymphoma: Increasing evidence of the importance of the microenvironment. J Clin Oncol 2011; 29: 1812 - 1826.